This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-27a-5p | ABAT | 0.1 | 0.90102 | 0.41 | 0.63594 | miRNATAP | -0.19 | 0.04218 | NA | |
2 | hsa-miR-93-5p | ABCA1 | -0.47 | 0.82637 | -0.04 | 0.9599 | MirTarget; miRNATAP | -0.38 | 0 | NA | |
3 | hsa-miR-93-5p | ABCD2 | -0.47 | 0.82637 | -0.25 | 0.61042 | MirTarget | -0.6 | 0 | NA | |
4 | hsa-miR-93-5p | ABHD2 | -0.47 | 0.82637 | 0.03 | 0.98501 | miRNATAP | -0.12 | 0.04107 | NA | |
5 | hsa-miR-93-5p | ABL2 | -0.47 | 0.82637 | 0.09 | 0.91468 | MirTarget | -0.15 | 3.0E-5 | NA | |
6 | hsa-miR-93-5p | ADAM19 | -0.47 | 0.82637 | -0.01 | 0.98753 | mirMAP | -0.3 | 0.00022 | NA | |
7 | hsa-miR-17-3p | ADAMTS15 | 0.16 | 0.91644 | -0.91 | 0.09979 | MirTarget; miRNATAP | -0.38 | 0.027 | NA | |
8 | hsa-miR-17-3p | ADAMTSL1 | 0.16 | 0.91644 | 0.05 | 0.90541 | mirMAP | -0.51 | 0 | NA | |
9 | hsa-miR-93-5p | ADARB1 | -0.47 | 0.82637 | -0.12 | 0.85953 | miRNAWalker2 validate; MirTarget | -0.28 | 0 | NA | |
10 | hsa-miR-93-5p | ADCY1 | -0.47 | 0.82637 | 0.18 | 0.62889 | mirMAP | -0.31 | 0.00607 | NA | |
11 | hsa-miR-93-5p | ADCY9 | -0.47 | 0.82637 | -0.2 | 0.81596 | mirMAP | -0.18 | 0.00019 | NA | |
12 | hsa-miR-17-3p | AGPAT4 | 0.16 | 0.91644 | 0.17 | 0.74406 | mirMAP | -0.54 | 0 | NA | |
13 | hsa-miR-93-5p | AHNAK | -0.47 | 0.82637 | -0.12 | 0.93956 | miRNATAP | -0.46 | 0 | NA | |
14 | hsa-miR-93-5p | AKAP13 | -0.47 | 0.82637 | -0.18 | 0.88348 | MirTarget; miRNATAP | -0.21 | 1.0E-5 | NA | |
15 | hsa-miR-17-3p | AKT3 | 0.16 | 0.91644 | 0.25 | 0.66912 | miRNATAP | -0.52 | 0 | NA | |
16 | hsa-miR-93-5p | AKT3 | -0.47 | 0.82637 | 0.25 | 0.66912 | miRNATAP | -0.76 | 0 | NA | |
17 | hsa-miR-93-5p | ALDH1A3 | -0.47 | 0.82637 | 0.39 | 0.62184 | mirMAP | -0.76 | 0 | NA | |
18 | hsa-miR-17-3p | ANGPTL1 | 0.16 | 0.91644 | 0.24 | 0.70436 | MirTarget | -1.51 | 0 | NA | |
19 | hsa-miR-93-5p | ANK2 | -0.47 | 0.82637 | -0.09 | 0.8433 | MirTarget; miRNATAP | -1.16 | 0 | NA | |
20 | hsa-miR-93-5p | ANKRD12 | -0.47 | 0.82637 | 0.06 | 0.93991 | MirTarget | -0.12 | 0.00484 | NA | |
21 | hsa-miR-93-5p | ANKRD29 | -0.47 | 0.82637 | 0.64 | 0.08037 | miRNAWalker2 validate; MirTarget | -0.53 | 1.0E-5 | NA | |
22 | hsa-miR-17-3p | ANKRD50 | 0.16 | 0.91644 | 0.03 | 0.97538 | MirTarget; miRNATAP | -0.23 | 0 | NA | |
23 | hsa-miR-93-5p | ANKRD50 | -0.47 | 0.82637 | 0.03 | 0.97538 | MirTarget; miRNATAP | -0.21 | 0 | NA | |
24 | hsa-miR-27a-5p | ANTXR1 | 0.1 | 0.90102 | 0.14 | 0.90557 | MirTarget | -0.25 | 0.01093 | NA | |
25 | hsa-miR-93-5p | APBB2 | -0.47 | 0.82637 | 0 | 0.99736 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.14 | 0.00474 | NA | |
26 | hsa-miR-20b-5p | APCDD1 | 0.28 | 0.48508 | 1.11 | 0.282 | MirTarget | -0.17 | 0.04915 | NA | |
27 | hsa-miR-93-5p | AR | -0.47 | 0.82637 | -0.38 | 0.58507 | mirMAP | -1.04 | 0 | NA | |
28 | hsa-miR-93-5p | ARHGAP1 | -0.47 | 0.82637 | -0.11 | 0.93344 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.19 | 0 | NA | |
29 | hsa-miR-93-5p | ARHGAP23 | -0.47 | 0.82637 | 0.05 | 0.9518 | mirMAP | -0.43 | 0 | NA | |
30 | hsa-miR-93-5p | ARHGAP24 | -0.47 | 0.82637 | -0.06 | 0.89635 | MirTarget | -0.57 | 0 | NA | |
31 | hsa-miR-93-5p | ARHGEF3 | -0.47 | 0.82637 | -0.03 | 0.9748 | MirTarget; miRNATAP | -0.16 | 8.0E-5 | NA | |
32 | hsa-miR-93-5p | ARID4B | -0.47 | 0.82637 | 0.11 | 0.90679 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.1 | 0.00082 | NA | |
33 | hsa-miR-93-5p | ARL10 | -0.47 | 0.82637 | 0.01 | 0.96883 | mirMAP | -0.51 | 0 | NA | |
34 | hsa-miR-93-5p | ARL4C | -0.47 | 0.82637 | -0.1 | 0.91679 | MirTarget; miRNATAP | -0.48 | 0 | NA | |
35 | hsa-miR-93-5p | ARL9 | -0.47 | 0.82637 | 0.42 | 0.51463 | miRNAWalker2 validate | -0.5 | 0.00024 | NA | |
36 | hsa-miR-93-5p | ARNT2 | -0.47 | 0.82637 | -0.28 | 0.615 | mirMAP | -0.44 | 0.00083 | NA | |
37 | hsa-miR-20b-5p | ARSD | 0.28 | 0.48508 | -0.06 | 0.95634 | mirMAP | -0.1 | 0.01104 | NA | |
38 | hsa-miR-93-5p | ASPA | -0.47 | 0.82637 | 0.11 | 0.88022 | mirMAP | -0.8 | 0 | NA | |
39 | hsa-miR-17-3p | ASTN1 | 0.16 | 0.91644 | 0.28 | 0.76516 | MirTarget | -0.97 | 0 | NA | |
40 | hsa-miR-93-5p | ATCAY | -0.47 | 0.82637 | 0.67 | 0.44599 | mirMAP | -1.02 | 0 | NA | |
41 | hsa-miR-93-5p | ATP1A2 | -0.47 | 0.82637 | -0.04 | 0.95085 | MirTarget | -1.89 | 0 | NA | |
42 | hsa-miR-93-5p | ATXN1 | -0.47 | 0.82637 | 0.04 | 0.96341 | miRNAWalker2 validate; miRNATAP | -0.25 | 0 | NA | |
43 | hsa-miR-93-5p | ATXN1L | -0.47 | 0.82637 | -0.1 | 0.92096 | miRNATAP | -0.11 | 0.00036 | NA | |
44 | hsa-miR-93-5p | BAG2 | -0.47 | 0.82637 | 0.07 | 0.91567 | miRNAWalker2 validate | -0.27 | 0.01276 | NA | |
45 | hsa-miR-93-5p | BBX | -0.47 | 0.82637 | 0.02 | 0.9851 | MirTarget; miRNATAP | -0.13 | 0.00012 | NA | |
46 | hsa-miR-17-3p | BCL9L | 0.16 | 0.91644 | 0.02 | 0.98781 | mirMAP | -0.12 | 0.00261 | NA | |
47 | hsa-miR-93-5p | BEND4 | -0.47 | 0.82637 | -0.11 | 0.88946 | mirMAP | -0.58 | 4.0E-5 | NA | |
48 | hsa-miR-93-5p | BHLHE41 | -0.47 | 0.82637 | 0.52 | 0.4886 | miRNATAP | -0.6 | 0 | NA | |
49 | hsa-miR-93-5p | BMPR2 | -0.47 | 0.82637 | 0.12 | 0.90786 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.29 | 0 | NA | |
50 | hsa-miR-93-5p | BNC2 | -0.47 | 0.82637 | 0.15 | 0.76233 | miRNATAP | -1.05 | 0 | NA | |
51 | hsa-miR-93-5p | BNIP2 | -0.47 | 0.82637 | 0.08 | 0.92524 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.13 | 0.00059 | NA | |
52 | hsa-miR-93-5p | BNIP3L | -0.47 | 0.82637 | -0.4 | 0.70779 | MirTarget | -0.12 | 0.04888 | NA | |
53 | hsa-miR-17-3p | BTBD7 | 0.16 | 0.91644 | -0.13 | 0.8883 | miRNATAP | -0.11 | 0.00049 | NA | |
54 | hsa-miR-17-3p | C15orf52 | 0.16 | 0.91644 | -0.08 | 0.91072 | mirMAP | -0.24 | 0.00136 | NA | |
55 | hsa-miR-17-3p | C1orf21 | 0.16 | 0.91644 | -0.11 | 0.91205 | mirMAP | -0.18 | 0.0105 | NA | |
56 | hsa-miR-93-5p | CA5B | -0.47 | 0.82637 | -0.22 | 0.62382 | mirMAP | -0.15 | 0.0047 | NA | |
57 | hsa-miR-17-3p | CACNA1E | 0.16 | 0.91644 | -0.51 | 0.36647 | miRNATAP | -0.51 | 0.00035 | NA | |
58 | hsa-miR-93-5p | CACNA1E | -0.47 | 0.82637 | -0.51 | 0.36647 | mirMAP | -0.62 | 4.0E-5 | NA | |
59 | hsa-miR-93-5p | CADM2 | -0.47 | 0.82637 | 0.76 | 0.4386 | miRNATAP | -0.87 | 0 | NA | |
60 | hsa-miR-93-5p | CALD1 | -0.47 | 0.82637 | 0.13 | 0.92312 | miRNATAP | -0.76 | 0 | NA | |
61 | hsa-miR-93-5p | CAMTA2 | -0.47 | 0.82637 | -0.01 | 0.99321 | MirTarget | -0.12 | 0.00446 | NA | |
62 | hsa-miR-93-5p | CAV2 | -0.47 | 0.82637 | 0.18 | 0.80695 | miRNAWalker2 validate | -0.48 | 0 | NA | |
63 | hsa-miR-93-5p | CBX7 | -0.47 | 0.82637 | -0.06 | 0.9429 | mirMAP | -0.4 | 0 | NA | |
64 | hsa-miR-93-5p | CCBE1 | -0.47 | 0.82637 | -0.02 | 0.97818 | mirMAP | -1.43 | 0 | NA | |
65 | hsa-miR-93-5p | CCNG2 | -0.47 | 0.82637 | -0.04 | 0.96901 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.14 | 0.00129 | NA | |
66 | hsa-miR-93-5p | CD274 | -0.47 | 0.82637 | -0.02 | 0.95972 | MirTarget; miRNATAP | -0.28 | 0.01757 | NA | |
67 | hsa-miR-93-5p | CD69 | -0.47 | 0.82637 | -0.08 | 0.84476 | miRNATAP | -0.28 | 0.0202 | NA | |
68 | hsa-miR-17-3p | CDK17 | 0.16 | 0.91644 | -0.03 | 0.96463 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
69 | hsa-miR-17-3p | CDO1 | 0.16 | 0.91644 | 0.35 | 0.55727 | MirTarget | -0.94 | 0 | NA | |
70 | hsa-miR-27a-5p | CELF5 | 0.1 | 0.90102 | -0.59 | 0.21561 | mirMAP | -0.35 | 0.00432 | NA | |
71 | hsa-miR-93-5p | CEP170 | -0.47 | 0.82637 | -0.01 | 0.98675 | MirTarget | -0.28 | 0 | NA | |
72 | hsa-miR-93-5p | CERCAM | -0.47 | 0.82637 | -0.1 | 0.9115 | MirTarget | -0.54 | 0 | NA | |
73 | hsa-miR-93-5p | CFL2 | -0.47 | 0.82637 | -0.06 | 0.92086 | MirTarget; miRNATAP | -0.56 | 0 | NA | |
74 | hsa-miR-93-5p | CHD5 | -0.47 | 0.82637 | 0.31 | 0.59864 | MirTarget; miRNATAP | -0.44 | 0.00093 | NA | |
75 | hsa-miR-93-5p | CHD9 | -0.47 | 0.82637 | -0.03 | 0.975 | MirTarget; miRNATAP | -0.16 | 8.0E-5 | NA | |
76 | hsa-miR-93-5p | CIC | -0.47 | 0.82637 | -0.14 | 0.89104 | miRNATAP | -0.11 | 0.00079 | NA | |
77 | hsa-miR-17-3p | CLIP3 | 0.16 | 0.91644 | 0.02 | 0.96975 | miRNATAP | -0.7 | 0 | NA | |
78 | hsa-miR-27a-5p | CLIP3 | 0.1 | 0.90102 | 0.02 | 0.96975 | miRNATAP | -0.3 | 2.0E-5 | NA | |
79 | hsa-miR-93-5p | CLIP4 | -0.47 | 0.82637 | -0.05 | 0.8934 | MirTarget | -0.93 | 0 | NA | |
80 | hsa-miR-93-5p | CNTNAP3 | -0.47 | 0.82637 | -0.26 | 0.63022 | MirTarget | -0.87 | 0 | NA | |
81 | hsa-miR-17-3p | COL12A1 | 0.16 | 0.91644 | 0.04 | 0.97928 | MirTarget; miRNATAP | -0.37 | 0.00016 | NA | |
82 | hsa-miR-93-5p | COL1A1 | -0.47 | 0.82637 | -0.12 | 0.95162 | mirMAP | -0.61 | 0 | NA | |
83 | hsa-miR-93-5p | COL4A3 | -0.47 | 0.82637 | -0.34 | 0.65324 | MirTarget; miRNATAP | -0.55 | 0.00189 | NA | |
84 | hsa-miR-27a-5p | COL9A3 | 0.1 | 0.90102 | 1.04 | 0.13989 | MirTarget | -0.34 | 0.01397 | NA | |
85 | hsa-miR-93-5p | CORO2B | -0.47 | 0.82637 | 0.6 | 0.10777 | MirTarget; miRNATAP | -0.86 | 0 | NA | |
86 | hsa-miR-93-5p | CPEB3 | -0.47 | 0.82637 | -0.04 | 0.91989 | miRNATAP | -0.13 | 0.00426 | NA | |
87 | hsa-miR-17-3p | CPNE8 | 0.16 | 0.91644 | -0.04 | 0.92677 | MirTarget | -0.22 | 0.00808 | NA | |
88 | hsa-miR-93-5p | CREB5 | -0.47 | 0.82637 | 0.4 | 0.40036 | MirTarget; miRNATAP | -0.3 | 0.00588 | NA | |
89 | hsa-miR-93-5p | CRIM1 | -0.47 | 0.82637 | 0.05 | 0.96442 | MirTarget; miRNATAP | -0.14 | 0.00157 | NA | |
90 | hsa-miR-93-5p | CRY2 | -0.47 | 0.82637 | -0.03 | 0.9668 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.17 | 0 | NA | |
91 | hsa-miR-93-5p | CRYBG3 | -0.47 | 0.82637 | -0.13 | 0.83349 | MirTarget; miRNATAP | -0.26 | 1.0E-5 | NA | |
92 | hsa-miR-93-5p | CSF1 | -0.47 | 0.82637 | -0.08 | 0.9101 | miRNATAP | -0.45 | 0 | NA | |
93 | hsa-miR-93-5p | CSGALNACT1 | -0.47 | 0.82637 | 0.26 | 0.68074 | MirTarget | -0.34 | 2.0E-5 | NA | |
94 | hsa-miR-93-5p | CTSK | -0.47 | 0.82637 | 0.03 | 0.97917 | MirTarget | -0.56 | 0 | NA | |
95 | hsa-miR-93-5p | CXorf36 | -0.47 | 0.82637 | 0.13 | 0.80812 | mirMAP | -0.53 | 0 | NA | |
96 | hsa-miR-93-5p | CYBRD1 | -0.47 | 0.82637 | 0.11 | 0.90715 | MirTarget | -0.82 | 0 | NA | |
97 | hsa-miR-93-5p | CYP26B1 | -0.47 | 0.82637 | 0.59 | 0.14311 | miRNATAP | -0.4 | 0.00065 | NA | |
98 | hsa-miR-93-5p | CYP2U1 | -0.47 | 0.82637 | -0.07 | 0.89867 | MirTarget | -0.29 | 1.0E-5 | NA | |
99 | hsa-miR-17-3p | CYTH3 | 0.16 | 0.91644 | 0.04 | 0.96043 | MirTarget | -0.12 | 0.00765 | NA | |
100 | hsa-miR-27a-5p | CYTH3 | 0.1 | 0.90102 | 0.04 | 0.96043 | mirMAP | -0.13 | 0.00055 | NA | |
101 | hsa-miR-93-5p | DAB2 | -0.47 | 0.82637 | 0.14 | 0.89972 | MirTarget; miRNATAP | -0.2 | 0.0041 | 24037530 | miR 93 directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer; We next identify that microRNA miR-93 functions as a potent repressor of DAB2 expression by directly targeting the 3'UTR of the DAB2 mRNA; Using in vitro and in vivo approaches we demonstrate that miR-93 overexpression has an important role in promoting lung cancer cell growth and that its oncogenic function is primarily mediated by downregulating DAB2 expression; The correlations of both low DAB2 and high miR-93 expression levels with poor patient survival strongly support the critical role of the miR-93/DAB2 pathway in determining lung cancer progression |
102 | hsa-miR-93-5p | DCBLD2 | -0.47 | 0.82637 | 0 | 0.99929 | MirTarget; miRNATAP | -0.33 | 0.0001 | NA | |
103 | hsa-miR-17-3p | DCLK1 | 0.16 | 0.91644 | 0.01 | 0.98653 | MirTarget; miRNATAP | -0.87 | 0 | NA | |
104 | hsa-miR-93-5p | DENND5B | -0.47 | 0.82637 | 0.03 | 0.95555 | MirTarget; miRNATAP | -0.21 | 0.00657 | NA | |
105 | hsa-miR-93-5p | DIXDC1 | -0.47 | 0.82637 | -0.07 | 0.91444 | mirMAP | -0.45 | 0 | NA | |
106 | hsa-miR-27a-5p | DLG2 | 0.1 | 0.90102 | 0.05 | 0.9264 | miRNATAP | -0.46 | 5.0E-5 | NA | |
107 | hsa-miR-93-5p | DMKN | -0.47 | 0.82637 | -0.47 | 0.50996 | miRNAWalker2 validate | -0.49 | 0.00546 | NA | |
108 | hsa-miR-17-3p | DNAJC18 | 0.16 | 0.91644 | -0.13 | 0.72848 | MirTarget | -0.21 | 0 | NA | |
109 | hsa-miR-93-5p | DOCK4 | -0.47 | 0.82637 | 0.02 | 0.97023 | MirTarget | -0.26 | 0.00199 | NA | |
110 | hsa-miR-17-3p | DOK6 | 0.16 | 0.91644 | 0.12 | 0.7148 | MirTarget | -0.6 | 0 | NA | |
111 | hsa-miR-17-3p | DPT | 0.16 | 0.91644 | 0.19 | 0.76162 | MirTarget | -1.1 | 0 | NA | |
112 | hsa-miR-93-5p | DPYD | -0.47 | 0.82637 | 0.07 | 0.90718 | MirTarget | -0.77 | 0 | NA | |
113 | hsa-miR-93-5p | DPYSL2 | -0.47 | 0.82637 | -0.16 | 0.88622 | MirTarget; miRNATAP | -0.23 | 0.00484 | NA | |
114 | hsa-miR-17-3p | DST | 0.16 | 0.91644 | 0.06 | 0.96207 | mirMAP; miRNATAP | -0.26 | 0 | NA | |
115 | hsa-miR-93-5p | DST | -0.47 | 0.82637 | 0.06 | 0.96207 | mirMAP | -0.33 | 0 | NA | |
116 | hsa-miR-93-5p | DSTYK | -0.47 | 0.82637 | -0.05 | 0.951 | miRNAWalker2 validate; miRNATAP | -0.18 | 0 | NA | |
117 | hsa-miR-17-3p | DUSP19 | 0.16 | 0.91644 | -0.03 | 0.90206 | mirMAP | -0.2 | 2.0E-5 | NA | |
118 | hsa-miR-17-3p | EBF1 | 0.16 | 0.91644 | 0.25 | 0.44838 | MirTarget; miRNATAP | -0.48 | 0 | NA | |
119 | hsa-miR-93-5p | ECE1 | -0.47 | 0.82637 | 0.12 | 0.92902 | mirMAP | -0.17 | 0.00025 | NA | |
120 | hsa-miR-93-5p | EDA2R | -0.47 | 0.82637 | 0.27 | 0.45282 | MirTarget | -0.51 | 2.0E-5 | NA | |
121 | hsa-miR-93-5p | EGR2 | -0.47 | 0.82637 | 0.02 | 0.9747 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.62 | 0 | NA | |
122 | hsa-miR-17-3p | EHD3 | 0.16 | 0.91644 | 0.21 | 0.66734 | MirTarget | -0.31 | 2.0E-5 | NA | |
123 | hsa-miR-93-5p | ELAVL2 | -0.47 | 0.82637 | 1.49 | 0.03805 | MirTarget; miRNATAP | -0.45 | 0.02718 | NA | |
124 | hsa-miR-17-3p | ELFN2 | 0.16 | 0.91644 | 0.07 | 0.88599 | mirMAP | -0.55 | 0.00028 | NA | |
125 | hsa-miR-93-5p | ELK3 | -0.47 | 0.82637 | 0.03 | 0.96415 | MirTarget; miRNATAP | -0.44 | 0 | NA | |
126 | hsa-miR-17-3p | ELOVL2 | 0.16 | 0.91644 | 0.16 | 0.75946 | miRNAWalker2 validate | -0.35 | 0.0017 | NA | |
127 | hsa-miR-17-3p | ENTPD1 | 0.16 | 0.91644 | -0.08 | 0.93919 | mirMAP | -0.24 | 0 | NA | |
128 | hsa-miR-93-5p | EPAS1 | -0.47 | 0.82637 | 0.02 | 0.98754 | miRNATAP | -0.25 | 0 | NA | |
129 | hsa-miR-93-5p | EPHA4 | -0.47 | 0.82637 | -0.07 | 0.90219 | miRNAWalker2 validate; miRNATAP | -0.7 | 0 | NA | |
130 | hsa-miR-93-5p | EPHA7 | -0.47 | 0.82637 | 0.16 | 0.77187 | miRNAWalker2 validate; miRNATAP | -0.89 | 0 | NA | |
131 | hsa-miR-93-5p | ETV1 | -0.47 | 0.82637 | 0.09 | 0.87424 | MirTarget; miRNATAP | -0.34 | 4.0E-5 | NA | |
132 | hsa-miR-93-5p | FAM117A | -0.47 | 0.82637 | -0.04 | 0.94562 | miRNATAP | -0.11 | 0.03928 | NA | |
133 | hsa-miR-93-5p | FAM129A | -0.47 | 0.82637 | 0.07 | 0.91871 | miRNAWalker2 validate | -0.84 | 0 | NA | |
134 | hsa-miR-17-3p | FAM19A1 | 0.16 | 0.91644 | -0.08 | 0.89505 | MirTarget | -0.52 | 8.0E-5 | NA | |
135 | hsa-miR-93-5p | FAM19A1 | -0.47 | 0.82637 | -0.08 | 0.89505 | MirTarget | -0.53 | 0.00016 | NA | |
136 | hsa-miR-93-5p | FAT3 | -0.47 | 0.82637 | 0.26 | 0.59295 | mirMAP | -0.81 | 0 | NA | |
137 | hsa-miR-93-5p | FAT4 | -0.47 | 0.82637 | -0.14 | 0.82442 | MirTarget; miRNATAP | -0.58 | 0 | NA | |
138 | hsa-miR-93-5p | FBXL5 | -0.47 | 0.82637 | 0.06 | 0.95442 | miRNAWalker2 validate; miRNATAP | -0.15 | 0 | NA | |
139 | hsa-miR-93-5p | FGD1 | -0.47 | 0.82637 | 0.03 | 0.95404 | MirTarget; miRNATAP | -0.2 | 0.02482 | NA | |
140 | hsa-miR-93-5p | FGD5 | -0.47 | 0.82637 | 0.06 | 0.93238 | MirTarget; miRNATAP | -0.49 | 0 | NA | |
141 | hsa-miR-93-5p | FGFR1 | -0.47 | 0.82637 | -0 | 0.99975 | mirMAP | -0.67 | 0 | NA | |
142 | hsa-miR-93-5p | FGL2 | -0.47 | 0.82637 | -0.4 | 0.60105 | MirTarget | -0.52 | 0 | NA | |
143 | hsa-miR-93-5p | FIBIN | -0.47 | 0.82637 | 0.31 | 0.61256 | MirTarget | -0.76 | 0 | NA | |
144 | hsa-miR-93-5p | FKBP7 | -0.47 | 0.82637 | 0.07 | 0.89678 | miRNAWalker2 validate | -0.32 | 0 | NA | |
145 | hsa-miR-93-5p | FLT1 | -0.47 | 0.82637 | 0.22 | 0.79856 | MirTarget; miRNATAP | -0.29 | 0 | NA | |
146 | hsa-miR-27a-5p | FN1 | 0.1 | 0.90102 | 0.13 | 0.94049 | MirTarget | -0.35 | 0.00209 | NA | |
147 | hsa-miR-17-3p | FOSL2 | 0.16 | 0.91644 | -0.14 | 0.89993 | mirMAP | -0.11 | 0.02297 | NA | |
148 | hsa-miR-17-3p | FOXP1 | 0.16 | 0.91644 | -0.25 | 0.81645 | MirTarget; miRNATAP | -0.17 | 0.00025 | NA | |
149 | hsa-miR-17-3p | FOXP3 | 0.16 | 0.91644 | -0.38 | 0.33932 | MirTarget | -0.31 | 0.00274 | NA | |
150 | hsa-miR-20b-5p | FOXQ1 | 0.28 | 0.48508 | 0.46 | 0.63909 | MirTarget | -0.17 | 0.01371 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL DEVELOPMENT | 80 | 1426 | 1.298e-11 | 6.041e-08 |
2 | NEUROGENESIS | 78 | 1402 | 3.665e-11 | 8.527e-08 |
3 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 41 | 513 | 9.394e-11 | 1.457e-07 |
4 | POSITIVE REGULATION OF GENE EXPRESSION | 87 | 1733 | 4.541e-10 | 4.454e-07 |
5 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 55 | 872 | 4.786e-10 | 4.454e-07 |
6 | TISSUE DEVELOPMENT | 79 | 1518 | 6.454e-10 | 5.005e-07 |
7 | REGULATION OF CELL DIFFERENTIATION | 77 | 1492 | 1.608e-09 | 1.069e-06 |
8 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 20 | 162 | 5.555e-09 | 3.231e-06 |
9 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 58 | 1021 | 7.592e-09 | 3.925e-06 |
10 | NEURON DIFFERENTIATION | 52 | 874 | 1.068e-08 | 4.968e-06 |
11 | REGULATION OF CELL DEVELOPMENT | 50 | 836 | 1.769e-08 | 7.483e-06 |
12 | SKELETAL SYSTEM DEVELOPMENT | 34 | 455 | 2.136e-08 | 8.282e-06 |
13 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 79 | 1672 | 4.711e-08 | 1.686e-05 |
14 | ORGAN MORPHOGENESIS | 49 | 841 | 5.593e-08 | 1.735e-05 |
15 | POSITIVE REGULATION OF CELL DEVELOPMENT | 34 | 472 | 5.223e-08 | 1.735e-05 |
16 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 83 | 1805 | 6.665e-08 | 1.824e-05 |
17 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 55 | 1004 | 6.503e-08 | 1.824e-05 |
18 | CELLULAR COMPONENT MORPHOGENESIS | 51 | 900 | 7.103e-08 | 1.836e-05 |
19 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 29 | 368 | 7.668e-08 | 1.878e-05 |
20 | REGULATION OF CELL MORPHOGENESIS | 37 | 552 | 8.494e-08 | 1.976e-05 |
21 | REGULATION OF NEURON DIFFERENTIATION | 37 | 554 | 9.307e-08 | 2.062e-05 |
22 | NEURON PROJECTION MORPHOGENESIS | 30 | 402 | 1.509e-07 | 3.193e-05 |
23 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 81 | 1784 | 1.686e-07 | 3.411e-05 |
24 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 44 | 750 | 2.287e-07 | 4.257e-05 |
25 | REGULATION OF GTPASE ACTIVITY | 41 | 673 | 2.243e-07 | 4.257e-05 |
26 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 76 | 1656 | 2.842e-07 | 4.729e-05 |
27 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 63 | 1275 | 2.806e-07 | 4.729e-05 |
28 | REGULATION OF SYSTEM PROCESS | 34 | 507 | 2.846e-07 | 4.729e-05 |
29 | REGULATION OF CELL PROJECTION ORGANIZATION | 36 | 558 | 3.234e-07 | 5.133e-05 |
30 | HEAD DEVELOPMENT | 42 | 709 | 3.369e-07 | 5.133e-05 |
31 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 45 | 788 | 3.53e-07 | 5.133e-05 |
32 | CIRCULATORY SYSTEM DEVELOPMENT | 45 | 788 | 3.53e-07 | 5.133e-05 |
33 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 80 | 1791 | 3.97e-07 | 5.598e-05 |
34 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 46 | 823 | 4.764e-07 | 6.52e-05 |
35 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 26 | 337 | 5.458e-07 | 7.256e-05 |
36 | INTRACELLULAR SIGNAL TRANSDUCTION | 72 | 1572 | 6.611e-07 | 8.409e-05 |
37 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 29 | 408 | 6.687e-07 | 8.409e-05 |
38 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 23 | 278 | 7.413e-07 | 9.077e-05 |
39 | CARTILAGE DEVELOPMENT | 16 | 147 | 1.057e-06 | 0.0001261 |
40 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 24 | 306 | 1.113e-06 | 0.0001295 |
41 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 48 | 905 | 1.189e-06 | 0.0001344 |
42 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 43 | 771 | 1.213e-06 | 0.0001344 |
43 | VASCULATURE DEVELOPMENT | 31 | 469 | 1.304e-06 | 0.0001411 |
44 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 69 | 1518 | 1.528e-06 | 0.0001616 |
45 | TELENCEPHALON DEVELOPMENT | 20 | 228 | 1.587e-06 | 0.0001641 |
46 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 72 | 1618 | 1.9e-06 | 0.0001892 |
47 | BIOLOGICAL ADHESION | 52 | 1032 | 1.911e-06 | 0.0001892 |
48 | POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT | 20 | 232 | 2.077e-06 | 0.0002014 |
49 | CONNECTIVE TISSUE DEVELOPMENT | 18 | 194 | 2.37e-06 | 0.000225 |
50 | NEURON DEVELOPMENT | 39 | 687 | 2.534e-06 | 0.0002329 |
51 | CEREBRAL CORTEX DEVELOPMENT | 13 | 105 | 2.552e-06 | 0.0002329 |
52 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 29 | 437 | 2.655e-06 | 0.0002375 |
53 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 23 | 303 | 3.236e-06 | 0.0002841 |
54 | POSITIVE REGULATION OF LOCOMOTION | 28 | 420 | 3.618e-06 | 0.0003117 |
55 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 55 | 1142 | 3.701e-06 | 0.0003131 |
56 | EPITHELIUM DEVELOPMENT | 48 | 945 | 3.916e-06 | 0.0003201 |
57 | NEURON PROJECTION DEVELOPMENT | 33 | 545 | 3.99e-06 | 0.0003201 |
58 | SKELETAL SYSTEM MORPHOGENESIS | 18 | 201 | 3.923e-06 | 0.0003201 |
59 | REGULATION OF HYDROLASE ACTIVITY | 61 | 1327 | 4.657e-06 | 0.0003558 |
60 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 51 | 1036 | 4.664e-06 | 0.0003558 |
61 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 51 | 1036 | 4.664e-06 | 0.0003558 |
62 | REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION | 17 | 184 | 4.77e-06 | 0.000358 |
63 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 8 | 39 | 4.971e-06 | 0.0003671 |
64 | MUSCLE STRUCTURE DEVELOPMENT | 28 | 432 | 6.164e-06 | 0.0004482 |
65 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 19 | 229 | 6.51e-06 | 0.000466 |
66 | MUSCLE TISSUE DEVELOPMENT | 21 | 275 | 7.861e-06 | 0.0005527 |
67 | LOCOMOTION | 53 | 1114 | 7.959e-06 | 0.0005527 |
68 | POSITIVE REGULATION OF AXONOGENESIS | 10 | 69 | 8.922e-06 | 0.0006105 |
69 | BEHAVIOR | 31 | 516 | 9.159e-06 | 0.0006176 |
70 | BONE DEVELOPMENT | 15 | 156 | 1.061e-05 | 0.0007053 |
71 | POSITIVE REGULATION OF CELL COMMUNICATION | 66 | 1532 | 1.53e-05 | 0.001003 |
72 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 37 | 689 | 1.588e-05 | 0.001026 |
73 | RESPONSE TO ENDOGENOUS STIMULUS | 63 | 1450 | 1.885e-05 | 0.001194 |
74 | POSITIVE REGULATION OF AUTOPHAGY | 10 | 75 | 1.899e-05 | 0.001194 |
75 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 61 | 1395 | 2.142e-05 | 0.001329 |
76 | NEURON MIGRATION | 12 | 110 | 2.288e-05 | 0.001382 |
77 | REGULATION OF BLOOD CIRCULATION | 21 | 295 | 2.272e-05 | 0.001382 |
78 | HEART DEVELOPMENT | 28 | 466 | 2.473e-05 | 0.001475 |
79 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 46 | 957 | 2.535e-05 | 0.001493 |
80 | REGULATION OF AXONOGENESIS | 15 | 168 | 2.572e-05 | 0.001496 |
81 | SENSORY ORGAN DEVELOPMENT | 29 | 493 | 2.623e-05 | 0.001507 |
82 | POSITIVE REGULATION OF AXON EXTENSION | 7 | 36 | 2.847e-05 | 0.001616 |
83 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 38 | 740 | 3.256e-05 | 0.001826 |
84 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 31 | 554 | 3.618e-05 | 0.001961 |
85 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 40 | 799 | 3.566e-05 | 0.001961 |
86 | PALLIUM DEVELOPMENT | 14 | 153 | 3.624e-05 | 0.001961 |
87 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 77 | 1929 | 4.007e-05 | 0.002143 |
88 | FOREBRAIN DEVELOPMENT | 23 | 357 | 4.533e-05 | 0.002389 |
89 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 37 | 724 | 4.577e-05 | 0.002389 |
90 | EMBRYO DEVELOPMENT | 43 | 894 | 4.62e-05 | 0.002389 |
91 | SINGLE ORGANISM BEHAVIOR | 24 | 384 | 5.042e-05 | 0.002563 |
92 | REGULATION OF EXTENT OF CELL GROWTH | 11 | 101 | 5.068e-05 | 0.002563 |
93 | REGULATION OF DEVELOPMENTAL GROWTH | 20 | 289 | 5.268e-05 | 0.002636 |
94 | BLOOD VESSEL MORPHOGENESIS | 23 | 364 | 6.101e-05 | 0.00302 |
95 | EMBRYONIC SKELETAL SYSTEM DEVELOPMENT | 12 | 122 | 6.419e-05 | 0.003144 |
96 | MULTICELLULAR ORGANISMAL SIGNALING | 12 | 123 | 6.952e-05 | 0.00337 |
97 | NEURON PROJECTION GUIDANCE | 16 | 205 | 7.207e-05 | 0.003457 |
98 | REGULATION OF PROTEIN MODIFICATION PROCESS | 69 | 1710 | 7.656e-05 | 0.003635 |
99 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 28 | 498 | 7.908e-05 | 0.003717 |
100 | CELL PART MORPHOGENESIS | 33 | 633 | 8.093e-05 | 0.003764 |
101 | TUBE DEVELOPMENT | 30 | 552 | 8.169e-05 | 0.003764 |
102 | ACTIN FILAMENT BASED PROCESS | 26 | 450 | 9.129e-05 | 0.004164 |
103 | SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 22 | 352 | 0.0001028 | 0.004637 |
104 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 50 | 1135 | 0.0001037 | 0.004637 |
105 | VASCULOGENESIS | 8 | 59 | 0.0001149 | 0.005094 |
106 | CELL PROJECTION ORGANIZATION | 42 | 902 | 0.0001162 | 0.0051 |
107 | EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS | 10 | 93 | 0.0001233 | 0.005312 |
108 | MUSCLE CELL DIFFERENTIATION | 17 | 237 | 0.0001227 | 0.005312 |
109 | CHONDROCYTE DIFFERENTIATION | 8 | 60 | 0.0001297 | 0.005487 |
110 | REGULATION OF CELL SIZE | 14 | 172 | 0.0001292 | 0.005487 |
111 | MEMBRANE DEPOLARIZATION | 8 | 61 | 0.000146 | 0.006067 |
112 | POSITIVE REGULATION OF STEM CELL PROLIFERATION | 8 | 61 | 0.000146 | 0.006067 |
113 | TAXIS | 26 | 464 | 0.0001492 | 0.006143 |
114 | CELLULAR RESPONSE TO ACID CHEMICAL | 14 | 175 | 0.0001551 | 0.006268 |
115 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 72 | 1848 | 0.0001553 | 0.006268 |
116 | PROTEIN PHOSPHORYLATION | 43 | 944 | 0.0001563 | 0.006268 |
117 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 45 | 1008 | 0.0001727 | 0.006811 |
118 | BONE MORPHOGENESIS | 9 | 79 | 0.0001717 | 0.006811 |
119 | POSITIVE REGULATION OF DEVELOPMENTAL GROWTH | 13 | 156 | 0.0001765 | 0.006903 |
120 | POSITIVE REGULATION OF CELL DEATH | 31 | 605 | 0.00018 | 0.006981 |
121 | REGULATION OF KINASE ACTIVITY | 37 | 776 | 0.0001868 | 0.007125 |
122 | REGULATION OF OSSIFICATION | 14 | 178 | 0.0001854 | 0.007125 |
123 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 34 | 0.0001895 | 0.007126 |
124 | CELL MOTILITY | 39 | 835 | 0.0001914 | 0.007126 |
125 | LOCALIZATION OF CELL | 39 | 835 | 0.0001914 | 0.007126 |
126 | REGULATION OF MEMBRANE POTENTIAL | 21 | 343 | 0.000195 | 0.0072 |
127 | REGULATION OF PHOSPHOLIPASE ACTIVITY | 8 | 64 | 0.0002054 | 0.007526 |
128 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 12 | 140 | 0.0002391 | 0.008693 |
129 | PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION | 4 | 13 | 0.0002432 | 0.008705 |
130 | PERIPHERAL NERVOUS SYSTEM NEURON DEVELOPMENT | 4 | 13 | 0.0002432 | 0.008705 |
131 | TISSUE MORPHOGENESIS | 28 | 533 | 0.0002454 | 0.008715 |
132 | NEGATIVE REGULATION OF GENE EXPRESSION | 60 | 1493 | 0.0002602 | 0.009172 |
133 | POSITIVE REGULATION OF KINASE ACTIVITY | 26 | 482 | 0.0002705 | 0.009462 |
134 | REGULATION OF ION TRANSPORT | 30 | 592 | 0.0002752 | 0.009486 |
135 | REGULATION OF CELL PROLIFERATION | 60 | 1496 | 0.0002742 | 0.009486 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CYTOSKELETAL PROTEIN BINDING | 50 | 819 | 9.127e-09 | 8.479e-06 |
2 | ENZYME BINDING | 81 | 1737 | 5.444e-08 | 2.529e-05 |
3 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 39 | 629 | 2.864e-07 | 6.763e-05 |
4 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 60 | 1199 | 3.64e-07 | 6.763e-05 |
5 | TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 26 | 328 | 3.244e-07 | 6.763e-05 |
6 | GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 24 | 303 | 9.342e-07 | 0.0001311 |
7 | SEQUENCE SPECIFIC DNA BINDING | 53 | 1037 | 9.878e-07 | 0.0001311 |
8 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING | 20 | 226 | 1.383e-06 | 0.0001606 |
9 | TUBULIN BINDING | 22 | 273 | 1.995e-06 | 0.0002059 |
10 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 11 | 81 | 6.093e-06 | 0.0004777 |
11 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 23 | 315 | 6.17e-06 | 0.0004777 |
12 | RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY | 19 | 228 | 6.11e-06 | 0.0004777 |
13 | VOLTAGE GATED SODIUM CHANNEL ACTIVITY | 6 | 20 | 7.38e-06 | 0.0005274 |
14 | REGULATORY REGION NUCLEIC ACID BINDING | 42 | 818 | 1.249e-05 | 0.0008286 |
15 | PROTEIN HOMODIMERIZATION ACTIVITY | 38 | 722 | 1.904e-05 | 0.001179 |
16 | MACROMOLECULAR COMPLEX BINDING | 61 | 1399 | 2.332e-05 | 0.001354 |
17 | PROTEIN KINASE ACTIVITY | 34 | 640 | 4.359e-05 | 0.002382 |
18 | CALCIUM ION BINDING | 36 | 697 | 4.668e-05 | 0.002409 |
19 | MOLECULAR FUNCTION REGULATOR | 58 | 1353 | 6.036e-05 | 0.002951 |
20 | GTPASE BINDING | 20 | 295 | 7.006e-05 | 0.003099 |
21 | GROWTH FACTOR BINDING | 12 | 123 | 6.952e-05 | 0.003099 |
22 | KINASE ACTIVITY | 40 | 842 | 0.0001111 | 0.004691 |
23 | RIBONUCLEOTIDE BINDING | 72 | 1860 | 0.0001886 | 0.007616 |
24 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY | 8 | 64 | 0.0002054 | 0.007633 |
25 | MICROTUBULE BINDING | 15 | 201 | 0.0001973 | 0.007633 |
26 | HORMONE BINDING | 8 | 65 | 0.0002291 | 0.008187 |
27 | BETA CATENIN BINDING | 9 | 84 | 0.0002746 | 0.00945 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEURON PROJECTION | 58 | 942 | 3.865e-10 | 2.257e-07 |
2 | NEURON PART | 67 | 1265 | 7.795e-09 | 2.276e-06 |
3 | CELL PROJECTION | 83 | 1786 | 4.198e-08 | 8.173e-06 |
4 | MEMBRANE REGION | 56 | 1134 | 1.397e-06 | 0.0002039 |
5 | SITE OF POLARIZED GROWTH | 15 | 149 | 6.058e-06 | 0.0007076 |
6 | VOLTAGE GATED SODIUM CHANNEL COMPLEX | 5 | 14 | 1.7e-05 | 0.001419 |
7 | MEMBRANE MICRODOMAIN | 21 | 288 | 1.587e-05 | 0.001419 |
8 | CELL JUNCTION | 53 | 1151 | 1.966e-05 | 0.001435 |
9 | AXON | 26 | 418 | 2.682e-05 | 0.00174 |
10 | CELL LEADING EDGE | 23 | 350 | 3.337e-05 | 0.001949 |
11 | EXCITATORY SYNAPSE | 16 | 197 | 4.474e-05 | 0.002058 |
12 | SODIUM CHANNEL COMPLEX | 5 | 17 | 4.934e-05 | 0.002058 |
13 | CYTOSKELETON | 78 | 1967 | 4.431e-05 | 0.002058 |
14 | SYNAPSE | 38 | 754 | 4.863e-05 | 0.002058 |
15 | PLASMA MEMBRANE REGION | 44 | 929 | 5.395e-05 | 0.0021 |
16 | PLASMA MEMBRANE RAFT | 10 | 86 | 6.327e-05 | 0.002309 |
17 | T TUBULE | 7 | 45 | 0.0001271 | 0.004318 |
18 | SOMATODENDRITIC COMPARTMENT | 33 | 650 | 0.0001331 | 0.004318 |
19 | CELL PROJECTION PART | 43 | 946 | 0.0001636 | 0.005029 |
20 | SYNAPSE PART | 31 | 610 | 0.000208 | 0.006073 |
21 | CELL SUBSTRATE JUNCTION | 23 | 398 | 0.0002286 | 0.006226 |
22 | DENDRITE | 25 | 451 | 0.0002345 | 0.006226 |
23 | POSTSYNAPSE | 22 | 378 | 0.0002818 | 0.007155 |
24 | CONTRACTILE FIBER | 15 | 211 | 0.0003332 | 0.007424 |
25 | PROTEINACEOUS EXTRACELLULAR MATRIX | 21 | 356 | 0.000322 | 0.007424 |
26 | EXTRACELLULAR MATRIX COMPONENT | 11 | 125 | 0.0003432 | 0.007424 |
27 | ANCHORING JUNCTION | 26 | 489 | 0.0003374 | 0.007424 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | Hippo_signaling_pathway_multiple_species_hsa04392 | 7 | 29 | 6.207e-06 | 0.0003228 | |
2 | PI3K_Akt_signaling_pathway_hsa04151 | 23 | 352 | 3.645e-05 | 0.0009478 | |
3 | Phospholipase_D_signaling_pathway_hsa04072 | 12 | 146 | 0.0003524 | 0.005008 | |
4 | MAPK_signaling_pathway_hsa04010 | 18 | 295 | 0.0005693 | 0.005008 | |
5 | Hippo_signaling_pathway_hsa04390 | 12 | 154 | 0.0005713 | 0.005008 | |
6 | Focal_adhesion_hsa04510 | 14 | 199 | 0.0005778 | 0.005008 | |
7 | ECM_receptor_interaction_hsa04512 | 8 | 82 | 0.001113 | 0.008265 | |
8 | Endocytosis_hsa04144 | 15 | 244 | 0.001482 | 0.009634 | |
9 | Rap1_signaling_pathway_hsa04015 | 13 | 206 | 0.002383 | 0.01297 | |
10 | Ras_signaling_pathway_hsa04014 | 14 | 232 | 0.002494 | 0.01297 | |
11 | Regulation_of_actin_cytoskeleton_hsa04810 | 12 | 208 | 0.006987 | 0.03303 | |
12 | Apelin_signaling_pathway_hsa04371 | 9 | 137 | 0.008271 | 0.03584 | |
13 | FoxO_signaling_pathway_hsa04068 | 8 | 132 | 0.01936 | 0.07744 | |
14 | cGMP_PKG_signaling_pathway_hsa04022 | 9 | 163 | 0.02339 | 0.08688 | |
15 | Sphingolipid_signaling_pathway_hsa04071 | 7 | 118 | 0.03073 | 0.1065 | |
16 | TGF_beta_signaling_pathway_hsa04350 | 5 | 84 | 0.06223 | 0.1903 | |
17 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 7 | 139 | 0.06396 | 0.1903 | |
18 | cAMP_signaling_pathway_hsa04024 | 9 | 198 | 0.06587 | 0.1903 | |
19 | Cytokine_cytokine_receptor_interaction_hsa04060 | 11 | 270 | 0.08375 | 0.2278 | |
20 | AMPK_signaling_pathway_hsa04152 | 6 | 121 | 0.08762 | 0.2278 | |
21 | Calcium_signaling_pathway_hsa04020 | 8 | 182 | 0.0926 | 0.2293 | |
22 | Autophagy_animal_hsa04140 | 6 | 128 | 0.1073 | 0.2393 | |
23 | Adherens_junction_hsa04520 | 4 | 72 | 0.11 | 0.2393 | |
24 | HIF_1_signaling_pathway_hsa04066 | 5 | 100 | 0.1105 | 0.2393 | |
25 | Tight_junction_hsa04530 | 7 | 170 | 0.1419 | 0.2951 | |
26 | Gap_junction_hsa04540 | 4 | 88 | 0.1844 | 0.3575 | |
27 | mTOR_signaling_pathway_hsa04150 | 6 | 151 | 0.1856 | 0.3575 | |
28 | Oocyte_meiosis_hsa04114 | 5 | 124 | 0.2069 | 0.3843 | |
29 | Jak_STAT_signaling_pathway_hsa04630 | 6 | 162 | 0.2293 | 0.4112 | |
30 | p53_signaling_pathway_hsa04115 | 3 | 68 | 0.248 | 0.4298 | |
31 | TNF_signaling_pathway_hsa04668 | 4 | 108 | 0.2933 | 0.492 | |
32 | Cell_adhesion_molecules_.CAMs._hsa04514 | 5 | 145 | 0.307 | 0.4988 | |
33 | ABC_transporters_hsa02010 | 2 | 45 | 0.3166 | 0.4988 | |
34 | Phosphatidylinositol_signaling_system_hsa04070 | 3 | 99 | 0.4606 | 0.7045 | |
35 | Mitophagy_animal_hsa04137 | 2 | 65 | 0.4933 | 0.7329 | |
36 | ErbB_signaling_pathway_hsa04012 | 2 | 85 | 0.6386 | 0.9027 | |
37 | Apoptosis_hsa04210 | 3 | 138 | 0.6834 | 0.9125 | |
38 | Wnt_signaling_pathway_hsa04310 | 3 | 146 | 0.7195 | 0.9125 | |
39 | Cellular_senescence_hsa04218 | 3 | 160 | 0.7749 | 0.9441 | |
40 | Neuroactive_ligand_receptor_interaction_hsa04080 | 5 | 278 | 0.8367 | 0.9888 | |
41 | Phagosome_hsa04145 | 2 | 152 | 0.9009 | 0.9996 | |
42 | Necroptosis_hsa04217 | 2 | 164 | 0.9227 | 0.9996 |